CohBar to Participate at Upcoming Conferences in June 2022
June 07 2022 - 9:00AM
CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company
leveraging the power of the mitochondria and the peptides encoded
in its genome to develop potential breakthrough therapeutics
targeting chronic and age-related diseases, announced today that
its Chief Executive Officer, Dr. Joseph Sarret, will participate at
two upcoming conferences.
BIO International Convention – June 13-16,
2022
- June 14th at 5:00 pm PT, San Diego, CA The presentation may be
accessed via webcast at the scheduled time for registered attendees
only.
4th Annual Longevity
Therapeutics Summit – June 28-30, 2022
- June 30th at 10:30 am PT, San Francisco, CA
- Dr. Sarret will be participating on a panel titled “Investing
in Longevity”, along with leaders from venture capital, large
pharmaceuticals, and innovative biotechs to discuss how to navigate
investments and funding in this lucrative field. Joining Dr. Sarret
on this panel is Anastasiya Giarletta, Principal at R42 Group, Kate
Batz, Director at Deep Knowledge Investors, and Karl Pfleger,
Founder at Agingbiotech.info.
About CohBar
CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company
leveraging the power of the mitochondria and the peptides encoded
in its genome to develop potential breakthrough therapeutics
targeting chronic and age-related diseases with limited to no
treatment options. CohBar has assembled the leading position in
exploring the mitochondrial genome and its utility for the
development of novel therapeutics, including world-renowned
expertise in mitochondrial biology, a broad intellectual property
estate, key opinion leaders and disciplined drug discovery and
development processes. CohBar is utilizing its Mito+ platform to
identify and develop modified versions of natural peptides called
analogs to treat a variety of serious conditions, with a focus on
diseases involving inflammation and fibrosis.
For additional company information, please visit www.cohbar.com
and engage with us on LinkedIn.
Forward-Looking Statements
This news release contains "forward-looking statements" as
defined by the Private Securities Litigation Reform Act of 1995.
CohBar cautions readers that forward-looking statements are based
on management's expectations and assumptions as of the date of this
news release and are subject to certain risks and uncertainties
that could cause actual results to differ materially. These
risks and uncertainties include, but are not limited to, risks and
uncertainties identified in the Company's filings with
the Securities and Exchange Commission. Forward-looking
statements reflect our analysis only on their stated date, and
CohBar takes no obligation to update or revise these statements
except as may be required by law.
Contacts: Jordyn TaraziDirector of Investor
RelationsCohBar, Inc.(650) 445-4441Jordyn.tarazi@cohbar.com
CohBar (NASDAQ:CWBR)
Historical Stock Chart
From Mar 2024 to Apr 2024
CohBar (NASDAQ:CWBR)
Historical Stock Chart
From Apr 2023 to Apr 2024